Cargando…
Role of Locoregional Treatment in De Novo Stage IV Breast Cancer
It is estimated that approximately 154000 women in the United States have stage IV breast cancer (BC). A subset of this group has metastatic disease at presentation, known as de novo stage IV disease. De novo stage IV BC accounts for approximately 6% of all BC diagnoses in the United States. Traditi...
Autores principales: | Lee, Joanna S, Toktas, Osman, Soran, Atilla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502854/ https://www.ncbi.nlm.nih.gov/pubmed/32994701 http://dx.doi.org/10.1177/1179554920942440 |
Ejemplares similares
-
Locoregional treatment of de novo stage IV breast cancer in the era of modern oncology
por: Merloni, Filippo, et al.
Publicado: (2023) -
Correspondence to “Locoregional therapy in de novo metastatic breast cancer: Systematic review and meta-analysis, written by Reinhorn D et al. In The Breast Journal 58 (2021) 173–181”
por: Soran, Atilla, et al.
Publicado: (2021) -
Role of locoregional surgery in patients with de novo stage IV breast cancer: analysis of real-world data from China
por: Ma, Li, et al.
Publicado: (2020) -
Locoregional therapy in luminal-like and HER2-enriched patients with de novo stage IV breast cancer
por: Chen, Peng-Yu, et al.
Publicado: (2013) -
Locoregional therapy of the primary tumour in de novo stage IV breast cancer in 216 066 patients: A meta-analysis
por: Gera, Ritika, et al.
Publicado: (2020)